Christof Von Eiff - Pharma

Author Information

C. von Eiff is a researcher affiliated with the Institute of Medical Microbiology at the University Hospital Münster (UKM) located in Münster, Germany. The focus of their work appears to be within the medical and microbiological fields, particularly concerning vaccination and infectious diseases.

Research Contributions

Christof Von Eiff has made significant contributions to the study of vaccination rates and adherence, particularly within the context of pneumococcal and tick-borne encephalitis in Germany. Recent research has also explored the dynamics of pneumococcal serotypes and vaccination patterns, especially among immunocompromised patients and premature infants. Additionally, Von Eiff has investigated bacterial pathogens such as Staphylococcus aureus, examining the efficacy of bacteriophage endolysins. This diverse body of work underscores a commitment to understanding and improving vaccination strategies and infectious disease management.

Aliases

Christof Von Eiff is also known by several variations of their name, including C Von Eiff and C. Von Eiff. These aliases are used interchangeably in scholarly publications.

Publication and Citation Metrics

Metric	Value
Number of Papers	134
Citation Count	8783
h-index	55

Publications:

Mathematical Modeling of Pneumococcal Serotype Dynamics in Germany

DOI: 10.2139/ssrn.4036427

Year: 2022

Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time

DOI: 10.1371/journal.pone.0265433

Year: 2022

Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.

DOI: 10.1016/j.vaccine.2020.12.047

Year: 2021

Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants - A claims database analysis in Germany.

DOI: 10.1016/j.vaccine.2021.11.002

Year: 2021

Ticks on the turf: investigating the presence of ixodid ticks on and around football fields in Germany

DOI: 10.1007/s10493-021-00628-0

Year: 2021

Pneumococcal Vaccination Rates in Immunocompromised Patients in Germany: A Retrospective Cohort Study to Assess Sequential Vaccination Rates and Changes Over Time

DOI: 10.2139/ssrn.3934040

Year: 2021

Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis.

DOI: 10.1016/j.vaccine.2021.04.029

Year: 2021

Population-based incidence and mortality of community-acquired pneumonia in Germany

DOI: 10.1371/journal.pone.0253118

Year: 2021

Pneumococcal vaccination rates in immunocompromised patients—A cohort study based on claims data from more than 200,000 patients in Germany

DOI: 10.1371/journal.pone.0220848

Year: 2019

In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types

DOI: 10.3390/ijms20030716

Year: 2019

What are the Challenges Faced by Generic Manufacturers?

Why is Generic Competition Important?

What is Pharma?

What are Collaborative Care Models?

What is a New Drug Application (NDA)?

How Can Technology Aid in Patient Education?

What Causes Adverse Drug Events?

How are ADEs Detected and Reported?

What is Cellular Stress?

What Are Clinical Trials?

Partnered Content Networks

Relevant Topics